Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals Inc. (INO)
Market is closed
News
- 1 - 10
- Next >>
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Inovio Third Quarter 2023 Financial Results Conference Call. At this time all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Inovio Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2023 Earnings Call Transcript
Operator: Good day and welcome to the Inovio First Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode for the duration of the call.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2022 Financial Results Conference Call. Please note, this event is being recorded.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2022 Earnings Call Transcript
Operator: Good day and welcome to the Inovio Third Quarter 2022 Results Conference Call. Please note that this event is being recorded. I would now like to turn the conference over to Thomas Hong.
10 Small-Cap Stocks to Sell Now Before Recession Begins
In this article, we discuss 10 small-cap stocks to sell now before recession begins.
5 Best Stocks Under $10 According to Billionaire Daniel Och's OZ Management
In this article, we discuss the 5 best stocks under $10 according to billionaire Daniel Och's OZ Management.
10 Best Vaccine Stocks to Buy Now
The mass COVID-19 vaccination drive has sent the stocks of publicly traded firms developing the vaccine into overdrive.
Inovio's (INO) INO-4800 can be a Valuable Vaccine Arsenal Upon FDA Approval
Wasatch Advisors, an employee-owned investment manager, published its ‘Wasatch Micro Cap Value Fund’ third-quarter 2020 Investor Letter – a copy of which can be downloaded here.
- 1 - 10
- Next >>
Billionaire Hedge Funds
